Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP392278.RAQRJVIlsgNfi2sOKmkxQH5nAqnbGL7dCACliYzHeWXpo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP392278.RAQRJVIlsgNfi2sOKmkxQH5nAqnbGL7dCACliYzHeWXpo130_assertion type Assertion NP392278.RAQRJVIlsgNfi2sOKmkxQH5nAqnbGL7dCACliYzHeWXpo130_head.
- NP392278.RAQRJVIlsgNfi2sOKmkxQH5nAqnbGL7dCACliYzHeWXpo130_assertion description "[Methylation frequencies of MLH1, MSH2, MSH6 and PMS2 promoter were 21.74%, 17.39%, 0% and 28.26% respectively in gastric cancer samples.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP392278.RAQRJVIlsgNfi2sOKmkxQH5nAqnbGL7dCACliYzHeWXpo130_provenance.
- NP392278.RAQRJVIlsgNfi2sOKmkxQH5nAqnbGL7dCACliYzHeWXpo130_assertion evidence source_evidence_literature NP392278.RAQRJVIlsgNfi2sOKmkxQH5nAqnbGL7dCACliYzHeWXpo130_provenance.
- NP392278.RAQRJVIlsgNfi2sOKmkxQH5nAqnbGL7dCACliYzHeWXpo130_assertion SIO_000772 19181186 NP392278.RAQRJVIlsgNfi2sOKmkxQH5nAqnbGL7dCACliYzHeWXpo130_provenance.
- NP392278.RAQRJVIlsgNfi2sOKmkxQH5nAqnbGL7dCACliYzHeWXpo130_assertion wasDerivedFrom befree-20140225 NP392278.RAQRJVIlsgNfi2sOKmkxQH5nAqnbGL7dCACliYzHeWXpo130_provenance.
- NP392278.RAQRJVIlsgNfi2sOKmkxQH5nAqnbGL7dCACliYzHeWXpo130_assertion wasGeneratedBy ECO_0000203 NP392278.RAQRJVIlsgNfi2sOKmkxQH5nAqnbGL7dCACliYzHeWXpo130_provenance.